# Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient

> **NCT02338752** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 20 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **BIOLOGICAL:** MV
- **OTHER:** Standard Treatment

## Key facts

- **NCT ID:** NCT02338752
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338752, "Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02338752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*